Competing interest reported. Competing interests
(i) Mustafa Kemal Çelen has served as a consultant for AbbVie, Gilead, MSD, Pharmactive, İlko, GSK, Abdi İbarahim, as a speaker for Gilead, MSD, Pharmactive, İlko, GSK, and has received research funding from AbbVie, Gilead, MSD, and GSK.
(ii) Buket Ertürk Şengel has served as a consultant for AbbVie and has received research funding from AbbVie.
(iii) Şafak Kaya has served as a consultant for AbbVie, as a speaker for Gilead, Abdi İbrahim, Pharmactive, and has received research funding from AbbVie.
(iv) Neşe Demirtürk has served as a speaker for Nobel, Gilead, Abdi İbrahim, and has received research funding from AbbVie.
(v) Alpay Azap has served as a consultant for AbbVie, and has received research funding from AbbVie.
(vi) Hüsnü Pullukçu has served as a consultant for AbbVie, Gilead, GSK, MSD, as a speaker for AbbVie, Gilead, GSK, İlko, MSD, and has received research funding from AbbVie, and Gilead.
(vii) Esma Eroğlu has received research funding from AbbVie.
(viii) Figen Yıldırım has served as a consultant for AbbVie, Gilead, GSK, Santa Farma, İlko, as a speaker for Gilead, GSK, Santa Farma, İlko, and has received research funding from AbbVie, and Gilead.
(ix) Hüseyin Şener Barut has received research funding from AbbVie.
(x) Esra Zerdali has served as a consultant for Gilead, GSK, MSD, as a speaker for Gilead, İlko, GSK, and has received research funding from AbbVie, and Gilead.
(xi) Ayşe Sağmak Tartar has served as a speaker for Pharmactive, Pfizer, Astellas, and has received research funding from AbbVie.
(xii) Ayşe Özlem Mete has served as a consultant for AbbVie, Gilead, has served as a speaker for AbbVie, Gilead, Pharmactive, Pfizer, GSK, Abdi İbrahim, has received research funding from AbbVie, Pfizer, Neutec, and has received congress participation support from Gilead, and Pfizer.
(xiii) Ahmet Melih Şahin has served as a consultant and a speaker for AbbVie, and has received research funding from AbbVie.
(xiv) Bedia Mutay Suntur has served as a speaker for Gilead, and has received research funding from AbbVie.
(xv) Nagehan Didem Sarı has served as a consultant for AbbVie, and has received research funding from AbbVie.
(xvi) Emel Yılmaz has served as a speaker for AbbVie, İlko, Abdi İbrahim, and has received research funding from AbbVie.
(xvii) Aslıhan Candevir has served as a consultant and a speaker for AbbVie, Gilead, Pfizer, GSK, Pharmactive, Santa Farma, and has received research funding from AbbVie, Gilead, Pfizer, GSK, Pharmactive, and Santa Farma.
(xviii) Funda Şimşek has served as a consultant and a speaker for Gilead, and has received research funding from AbbVie.
(xix) Dilara İnan has served as a consultant for Gilead, GSK, MSD, as a speaker for AbbVie, Gilead, GSK, İlko, MSD, and has received research funding from AbbVie.
(xx) Sıla Akhan has served as a consultant for AbbVie, and has received research funding from AbbVie.
(xxi) Ali Asan has served as a consultant for AbbVie, as a speaker for AbbVie, Gilead, and has received research funding from AbbVie, and Gilead.
(xxii) Özgür Günal has served as a consultant and a speaker for AbbVie, and has received research funding from AbbVie.
(xxiii) Onur Ural has received research funding from AbbVie.
(xxiv) Mehmet Parlak has received research funding from AbbVie.
(xxv) Mehmet Çabalak has served as a consultant and a speaker for AbbVie, Gilead, MSD, Pharmactive, and has received research funding from AbbVie.
(xxvi) Selçuk Nazik has served as a consultant for AbbVie, as a speaker for İlko, and has received research funding from AbbVie.
(xxvii) Kenan Hızel has received research funding from AbbVie.
(xxviii) Sami Kınıklı has served as a speaker for Gilead, and has received research funding from AbbVie.
(xxix) Zehra Beştepe Dursun has received research funding from AbbVie.
(xxx) Ayşe Batırel has served as a consultant and a speaker for Gilead, Pfizer, Santa Farma, and has received research funding from AbbVie.
(xxxi) Çiğdem Mermutluoğlu has no conflict of interest to declare.